This document is an excerpt from the EUR-Lex website
Document 52012AE0468
Opinion of the European Economic and Social Committee on the ‘Amended proposal for a Regulation of the European Parliament and of the Council amending Regulation (EC) No 726/2004 as regards information to the general public on medicinal products for human use subject to medical prescription and as regards pharmacovigilance’ COM(2011) 632 final — 2008/0255 (COD)
Opinion of the European Economic and Social Committee on the ‘Amended proposal for a Regulation of the European Parliament and of the Council amending Regulation (EC) No 726/2004 as regards information to the general public on medicinal products for human use subject to medical prescription and as regards pharmacovigilance’ COM(2011) 632 final — 2008/0255 (COD)
Opinion of the European Economic and Social Committee on the ‘Amended proposal for a Regulation of the European Parliament and of the Council amending Regulation (EC) No 726/2004 as regards information to the general public on medicinal products for human use subject to medical prescription and as regards pharmacovigilance’ COM(2011) 632 final — 2008/0255 (COD)
OJ C 143, 22.5.2012, p. 146–146
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
22.5.2012 |
EN |
Official Journal of the European Union |
C 143/146 |
Opinion of the European Economic and Social Committee on the ‘Amended proposal for a Regulation of the European Parliament and of the Council amending Regulation (EC) No 726/2004 as regards information to the general public on medicinal products for human use subject to medical prescription and as regards pharmacovigilance’
COM(2011) 632 final — 2008/0255 (COD)
2012/C 143/30
On 28 November 2011, the Council decided to consult the European Economic and Social Committee, under Articles 114 and 168(4)(c) of the Treaty on the Functioning of the European Union, on the
Amended proposal for a Regulation of the European Parliament and of the Council amending Regulation (EC) No 726/2004, as regards information to the general public on medical products for human use subject to medical prescription and as regards pharmacovigilance
COM(2011) 632 final – 2008/0255 (COD).
Since the Committee had already set out its views on the contents of the proposal in question in opinion CESE 1025/2009, adopted on 10 June 2009 (1), it decided at its 478th plenary session, held on 22 and 23 February 2012 (meeting of 22 February), by 119 votes in favour, with 6 abstentions, not to draw up a new opinion on the subject, but to refer to the position it had taken in the above-mentioned document.
Brussels, 22 February 2012.
The President of the European Economic and Social Committee
Staffan NILSSON
(1) OJ C 306, 16.12.2009, p. 33.